First-Line Therapy for Advanced NSCLC without Driver Mutations
Back to course
Video Transcription
Video Summary
Asset Subtitle
Ticiana Leal, MD
Keywords
NSCLC
immune checkpoint inhibitors
PD-L1
chemotherapy
CTLA-4 inhibitors
Powered By